Determination of levofloxacin by HPLC with fluorescence detection in human breast milk

Bioanalysis. 2021 Jul;13(13):1063-1070. doi: 10.4155/bio-2021-0058. Epub 2021 Jun 8.

Abstract

Aim: A new HPLC method with fluorescence detection has been developed and validated for the determination of levofloxacin, one of the fluoroquinolone class antibiotics, in breast milk. Materials & methods: Chromatographic separation was carried out on a reversed phase C18 column with acetonitrile and 10 mM o-phosphoric acid (25:75, v/v) mobile phase composition. Moxifloxacin was used as internal standard and the peaks were detected by fluorescence detection. Results & conclusion: Calibration graph was found linearly within the range of 2.5-500 ng/ml. Limit of detection and limit of quantification were found to be 0.63 and 2.11 ng/ml, respectively. Mean absolute recovery was 96.18%. The developed method has been successfully applied to the determination of levofloxacin in human breast milk taken from two healthy volunteers.

Keywords: HPLC; antibiotics; fluorescence detection; human breast milk; levofloxacin.

MeSH terms

  • Adult
  • Anti-Bacterial Agents / analysis*
  • Calibration
  • Chromatography, High Pressure Liquid / methods*
  • Female
  • Fluorescence
  • Fluoroquinolones / analysis*
  • Humans
  • Levofloxacin / analysis*
  • Milk, Human / chemistry*
  • Moxifloxacin / analysis
  • Reproducibility of Results

Substances

  • Anti-Bacterial Agents
  • Fluoroquinolones
  • Levofloxacin
  • Moxifloxacin